U

University of Michigan | Kellogg Eye Center

Research site

(Unclaimed)

Location

24 Frank Lloyd Wright Drive, Lobby G/Suite 1500, Ann Arbor, Michigan, United States of America

Site insights

Top conditions

Top treatments

NT-501

Linsitinib

Zimura

AU-011

Lidocaine

Elamipretide

Parent organization

This site is a part of University of Michigan

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 23 total trials

A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease

The study consists of a randomized double-masked, placebo-controlled, parallel-group, multicenter trial with an optional open-label treatment period...

Active, not recruiting

Thyroid Eye Disease

Other: Placebo

Biological: Teprotumumab

ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)

The goal of this clinical trial is to evaluate the efficacy, safety and pharmacokinetics of elamipretide in subjects with dry age-related macular deg...

Active, not recruiting

Age Related Macular Degeneration (ARMD)

Drug: Elamipretide

Drug: Placebo

Suprachoroidal Administration in Subjects With Metastases to the Choroid

The primary objective is to assess the safety and tolerability of bel-sar treatment in subjects with metastases to the choroid from any primary solid...

Enrolling

Eye Cancer

Primary Cancer

Device: SCS Microinjector

Device: Laser